Loading...
Loading...
FTRE| Name | Value |
|---|---|
| Revenues | 764.2M |
| Cost of Revenue | 639.7M |
| Gross Profit | 124.5M |
| Operating Expense | 103.6M |
| Operating I/L | 19.7M |
| Other Income/Expense | -4.6M |
| Interest Income | 0.1M |
| Pretax | -17.2M |
| Income Tax Expense | -5.6M |
| Net Income/Loss | -11.6M |
Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry, offering phase I-IV clinical trial management, clinical pharmacology, technology-enabled trial solutions, and post-approval services. The company generates revenue by providing these services to pharmaceutical, biotechnology, and medical device organizations.
